Comment on: Eculizumab as rescue therapy in refractory anti-NXP2 dermatomyositis with digestive vasculitis and gastrointestinal perforation: report of two case: Reply
Rheumatology (Oxford). 2026 Jan 13:keag019. doi: 10.1093/rheumatology/keag019. Online ahead of print. NO ABSTRACT PMID:41530555 | DOI:10.1093/rheumatology/keag019
